Follow
Generics
A generic drug is developed with the same dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use as a brand-name medication. Generics are known as bioequivalent to the name-brand drug, so they demonstrate the same degree of clinical benefit.
FEB 26, 2020 | 10:30 AM
QIAGEN CLC Genomics Workbench is a powerful solution to analyze and visualize next generation sequencing (NGS) data. Powered by cutting-edge technology and accelerated algorithms, it support...
FEB 26, 2020 | 9:00 AM
CRISPR revolutionized gene editing, but multi-target screening remains a complex goal. In addition, the fast pace of CRISPR technology development has brought sophisticated options for libra...
FEB 26, 2020 | 6:00 AM
Centhaquine (previously used names, centhaquin and PMZ-2010; International Non-proprietary Name (INN) recently approved by WHO is centhaquine) is being developed by us as a first-in-class re...
FEB 25, 2020 | 9:00 AM
Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
FEB 19, 2020 | 11:00 AM
DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
FEB 05, 2020 | 8:00 AM
C.E. CREDITS
Learn how new hemophilia and anticoagulant therapies impact coagulation assays and clinical decisions in our educational session....
JAN 23, 2020 | 9:00 AM
DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
JAN 14, 2020 | 9:00 AM
Fecal elastase-1 – a biomarker for pancreatic exocrine insufficiency(EPI) continues to gain traction as an ideal biomarker for assessing EPI. This presentation will include a review of...
JAN 09, 2020 | 10:00 AM
Join us on January 9, 2020 for this live webinar!...
JAN 01, 2020 | 6:00 AM
The aim of the lecture is to give an insight into the use of 3D liver micro tissues (3D liMTs) in drug discovery and translational safety. In translational toxicology, 3D LiMTs have a high i...
JAN 01, 2020 | 6:00 AM
“The poor translatability of early-stage preclinical models is a major setback in oncology drug development. Immortalized cell lines, that are extensively used in drug screens, undergo...
JAN 01, 2020 | 6:00 AM
Early phase clinical trials investigating novel applications of neural devices, such as deep brain stimulation (DBS) devices, pose ethical challenge during the recruitment of human subjects...
